From: Type I interferon pathway in adult and juvenile dermatomyositis
 | Healthy controls | Adult DM subjects | Juvenile DM subjects | |||||
---|---|---|---|---|---|---|---|---|
 | Median (n= 26) | 95% CI | Median (n= 56) | 95% CI | Pvalue | Median (n= 35) | 95% CI | Pvalue |
IFN gene scorea | 6.5 (n = 20) | 4.2 to 13.0 | 16.7 (n = 51) | 8.6 to 29.9 | 0.006 | 18.8 (n = 32) | 10.3 to 52.0 | 0.001 |
IFN chemokine scoreb | 3.9 | 2.8 to 4.5 | 19.1 | 10.2 to 27.8 | <0.0001 | 19.2 | 12.9 to 36.8 | <0.0001 |
IP-10c | 40.4 | 34.1 to 47.1 | 1066.9 | 240.2 to 1816.2 | <0.0001 | 881.9 | 427.9 to 2328.7 | <0.0001 |
ITAC | 29.0 | 22.6 to 39.6 | 202.6 | 101.0 to 376.0 | <0.0001 | 190.8 | 112.3 to 593.2 | <0.0001 |
MCP-1 | 339.1 | 280.3 to 430.6 | 954.8 | 630.9 to 1293.6 | <0.0001 | 850.3 | 749.2 to 1285.5 | <0.0001 |
Other chemokines and cytokines | Â | Â | Â | Â | Â | Â | Â | Â |
MIP-1β | 180.9 | 163.2 to 208.3 | 179.1 | 149.2 to 219.5 | 0.808 | 207.8 | 168.2 to 250 | 0.301 |
MIG | 15.7 | 12.0 to 18.7 | 100.0 | 60.57 to 143.6 | <0.0001 | 80.1 | 44.7 to 128.2 | <0.0001 |
IL-6 | 1.1 | 1.2 to 1.5 | 3.4 | 2.5 to 5.6 | <0.0001 | 5.3 | 3.2 to 9.5 | <0.0001 |
IL-8 | 15.0 | 11.8 to 19.2 | 8.4 | 6.0 to 3.0 | 0.002 | 8.2 | 6.5 to 13.4 | 0.003 |
IL-10 | 2.3 | 1.6 to 5.4 | 1.7 | 1.1 to 2.8 | 0.082 | 3.2 | 1.3 to 6.7 | 0.903 |
TNFα | 4.8 | 4.5 to 5.3 | 4.3 | 3.1 to 5.2 | 0.184 | 6.7 | 5.1 to 7.5 | 0.022 |